Cullinan Therapeutics, Inc. · NASDAQ:CGEM

Citadel Advisors LLC's stake in Cullinan Therapeutics, Inc. fell to 3.40% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Citadel Advisors LLC's stake in Cullinan Therapeutics, Inc. fell to 3.40%, 1,988,907 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
3.40%
Shares
1,988,907
Intent
Passive
What changed
Fell below 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC3.10%1,841,079
Citadel Advisors Holdings LP3.10%1,841,079
Citadel GP LLC3.10%1,841,079
Citadel Securities LLC0.30%147,828
Citadel Securities Group LP0.30%147,828
Citadel Securities GP LLC0.30%147,828
Kenneth Griffin3.40%1,988,907

Source

View original at SEC

Related